400 related articles for article (PubMed ID: 15907526)
1. Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
Matthai WH; Hursting MJ; Lewis BE; Kelton JG
Thromb Res; 2005; 116(2):121-6. PubMed ID: 15907526
[TBL] [Abstract][Full Text] [Related]
2. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
[TBL] [Abstract][Full Text] [Related]
3. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
Bartholomew JR; Pietrangeli CE; Hursting MJ
Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
[TBL] [Abstract][Full Text] [Related]
4. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
[TBL] [Abstract][Full Text] [Related]
5. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
[TBL] [Abstract][Full Text] [Related]
6. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
Levine RL; Hursting MJ; McCollum D
Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
[TBL] [Abstract][Full Text] [Related]
7. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Dager WE; White RH
Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
[TBL] [Abstract][Full Text] [Related]
8. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Berkowitz SD; Matthai WH; Fareed J; Walenga JM; Bartholomew J; Sham R; Lerner RG; Zeigler ZR; Rustagi PK; Jang IK; Rifkin SD; Moran J; Hursting MJ; Kelton JG;
Circulation; 2001 Apr; 103(14):1838-43. PubMed ID: 11294800
[TBL] [Abstract][Full Text] [Related]
9. Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study.
Young G; Boshkov LK; Sullivan JE; Raffini LJ; Cox DS; Boyle DA; Kallender H; Tarka EA; Soffer J; Hursting MJ
Pediatr Blood Cancer; 2011 Jul; 56(7):1103-9. PubMed ID: 21488155
[TBL] [Abstract][Full Text] [Related]
10. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
Guzzi LM; McCollum DA; Hursting MJ
J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
Hursting MJ; Verme-Gibboney CN
J Cardiovasc Pharmacol; 2008 Dec; 52(6):561-6. PubMed ID: 19057393
[TBL] [Abstract][Full Text] [Related]
12. Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
Bartholomew JR; Hursting MJ
J Thromb Thrombolysis; 2005 Jun; 19(3):183-8. PubMed ID: 16082605
[TBL] [Abstract][Full Text] [Related]
13. Argatroban dosing in patients with heparin-induced thrombocytopenia.
Verme-Gibboney CN; Hursting MJ
Ann Pharmacother; 2003; 37(7-8):970-5. PubMed ID: 12841802
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
Frame JN; Rice L; Bartholomew JR; Whelton A
Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232
[TBL] [Abstract][Full Text] [Related]
15. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
[TBL] [Abstract][Full Text] [Related]
16. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R
Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371
[TBL] [Abstract][Full Text] [Related]
17. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
Lewis BE; Matthai WH; Cohen M; Moses JW; Hursting MJ; Leya F;
Catheter Cardiovasc Interv; 2002 Oct; 57(2):177-84. PubMed ID: 12357516
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
Kiser TH; Jung R; MacLaren R; Fish DN
Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST
Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390
[TBL] [Abstract][Full Text] [Related]
20. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.
Tang IY; Cox DS; Patel K; Reddy BV; Nahlik L; Trevino S; Murray PT
Ann Pharmacother; 2005 Feb; 39(2):231-6. PubMed ID: 15632219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]